Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON56629
NL-OMON56629
Not yet recruiting
Not Applicable

A prospective longitudinal study of spinal cord lesions in multiple sclerosis: MRI monitoring and prognostic factors for active disease - MSpine

Zuyderland Medisch Centrum0 sites155 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Zuyderland Medisch Centrum
Enrollment
155
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Zuyderland Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •Patients diagnosed with relapsing\-remitting MS (\<5 years of first clinical
  • •Patient between 18\-65 years old
  • •Treatment\-naïve patients starting (a currently in the Netherlands approved) DMT
  • •(disease modifying treatment)

Exclusion Criteria

  • •Patients who are \<18 years old
  • •Patients who are \>65 years old
  • •Patients who presented first clinical event more than five years ago
  • •Patients who have already started DMT
  • •Patients who are incapable of giving informed consent
  • •Patients who are unable to undergo local MRI scan, due to for instance:
  • •Physical problems, for instance due to size/obesity (not fitting in regular MRI
  • •scanner), not being able to lie flat for extended periods of time (e.g. due to
  • •pain, shortness of breath). Due to claustrophobia.
  • •Patients who have contraindications for MRI scan, for instance due to

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The effects of spinal cord stimulation on nerve function in low back paiower back painLower back painMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disorders
ACTRN12617000239369orthern Sydney Local Health District30
Not yet recruiting
Not Applicable
Study on spinal anaesthesia failures in caesarean operatioHealth Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
CTRI/2021/01/030255Dr Suvarna Kaniyil
Not yet recruiting
Not Applicable
Elucidation of the effect of short-term spinal cord stimulation therapy on resting state functional connectivity networkintractable pain in limbs
JPRN-UMIN000031253Division of Anesthesiology, Department of Surgery Related,Kobe university graduate school of medicine60
Active, not recruiting
Phase 1
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsSpinal Muscular AtrophyMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2021-006781-21-BEovartis Pharma AG260
Active, not recruiting
Phase 1
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsSpinal Muscular AtrophyMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2021-006781-21-FRovartis Pharma AG260